Lipoprotein (a) levels, apolipoprotein (a) phenotypes and thyroid autoimmunity

被引:6
作者
Bairaktari, ET
Tselepis, AD
Millionis, HJ
Elisaf, MS [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Biochem Lab, Dept Chem, GR-45110 Ioannina, Greece
[3] Univ Hosp, Biochem Lab, Ioannina, Greece
关键词
D O I
10.1530/eje.0.1400474
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been reported that euthyroid normolipidemic males and postmenopausal females exhibit significantly higher serum lipoprotein (a) (Lp(a)) levels compared with age- and sex-matched normolipidemic controls. However, it is well known that there is an inverse correlation between Lp(a) concentration and apolipoprotein (a) (apo(a)) isoform size. Thus, it is imperative to exclude differences in apo(a) isoform frequencies between subjects with or without thyroid autoimmunity in order to verify if there is an association between thyroid autoimmunity and increased Lp(a) concentration. To exclude such an effect of different apo(a) isoform frequencies, we determined apo(a) phenotypes in 22 patients (9 males and 13 postmenopausal females) with thyroid autoimmunity and in 64 (29 males and 35 females) age- and sex-matched individuals without thyroid autoimmunity (control group). There were no significant differences in the values of lipid parameters between the two groups, including Lp(a). We did not detect any significant differences in the apo(a) phenotype frequencies between the two groups. Additionally, in neither of the subgroups formed according to the presence of low molecular vs high molecular weight apo(a) isoforms were there any significant differences in median serum Lp(a) levels between patients with and without thyroid autoimmunity. Thus, our results contradict the previously reported association between thyroid autoimmunity and Lp(a) concentrations.
引用
收藏
页码:474 / 476
页数:3
相关论文
共 14 条
[1]  
AUSTIN MA, 1992, AM J HUM GENET, V51, P829
[2]  
BERG K, 1963, ACTA PATHOL MIC SC, V59, P369
[3]   APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS [J].
BOERWINKLE, E ;
LEFFERT, CC ;
LIN, JP ;
LACKNER, C ;
CHIESA, G ;
HOBBS, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :52-60
[4]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[5]   LP(A) LIPOPROTEIN, IGG, IGA AND IGM ANTIBODIES TO CHLAMYDIA-PNEUMONIAE AND HLA CLASS-II GENOTYPE IN EARLY CORONARY-ARTERY DISEASE [J].
DAHLEN, GH ;
BOMAN, J ;
BIRGANDER, LS ;
LINDBLOM, B .
ATHEROSCLEROSIS, 1995, 114 (02) :165-174
[6]   POTENTIAL ENVIRONMENTAL-EFFECTS ON ADULT LIPOPROTEIN(A) LEVELS - RESULTS FROM SWEDISH TWINS [J].
HONG, YL ;
DAHLEN, GH ;
PEDERSEN, N ;
HELLER, DA ;
MCCLEARN, GE ;
DEFAIRE, U .
ATHEROSCLEROSIS, 1995, 117 (02) :295-304
[7]   PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro [J].
Karabina, SAP ;
Elisaf, MC ;
Goudevenos, J ;
Siamopoulos, KC ;
Sideris, D ;
Tselepis, AD .
ATHEROSCLEROSIS, 1996, 125 (01) :121-134
[8]   Lipoprotein(a) increase associated with thyroid autoimmunity [J].
Lotz, H ;
Salabe, GB .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (01) :87-91
[9]  
MILIONIS HJ, 1999, IN PRESS AM J KIDNEY
[10]   Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy [J].
Paoli, M ;
Bellabarba, G ;
Velazquez, E ;
Mendoza, S ;
Molina, C ;
Wang, P ;
Glueck, CJ .
CLINICA CHIMICA ACTA, 1998, 275 (01) :81-91